The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review

Documenti analoghi

• Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors
  di: Kellye Eagan, et al.
  Pubblicazione: (2025)
• ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
  di: Lena Makortoff, et al.
  Pubblicazione: (2024)
• Albuminuria‐based stratification of end‐stage kidney disease progression and mortality with sodium‐glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease
  di: Tien‐Jyun Chang, et al.
  Pubblicazione: (2024)
• Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation
  di: Spenser E. January, et al.
  Pubblicazione: (2025)
• Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
  di: C. Michael White, et al.
  Pubblicazione: (2024)